The Worst Itch Numeric Rating Scale for patients with moderate to severe plaque psoriasis or psoriatic arthritis

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-4632|54|6|715-722

ISSN： 0011-9059

Source： INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol.54, Iss.6, 2015-06, pp. : 715-722

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economic and Comorbidity Burden Among Moderate‐to‐Severe Psoriasis Patients with Comorbid Psoriatic Arthritis

By  

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 5, 2015-05 ,pp. : 708-717

John Wiley & Sons Inc

Access to resources Recommend Favorite

Otezla for plaque psoriasis and psoriatic arthritis

By  

PRESCRIBER, Vol. 26, Iss. 13-16, 2015-07 ,pp. : 33-35

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics, Immunogenicity, and Efficacy of Etanercept in Pediatric Patients With Moderate to Severe Plaque Psoriasis

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 58, Iss. 3, 2018-03 ,pp. : 340-346

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of open‐label ixekizumab treatment in Japanese patients with moderate‐to‐severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 6, 2015-06 ,pp. : 1148-1155

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adalimumab in the treatment of moderate‐to‐severe chronic plaque psoriasis in patients switching from other biologics

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 9, 2015-09 ,pp. : 1742-1749

John Wiley & Sons Inc

Access to resources Recommend Favorite